Request for Covid-19 Impact Assessment of this Report
The United States Human Hepatitis B Immunoglobulin(HBIG) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Hepatitis B Immunoglobulin(HBIG) market, reaching US$ million by the year 2028. As for the Europe Human Hepatitis B Immunoglobulin(HBIG) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Hepatitis B Immunoglobulin(HBIG) players cover Baxter, CSL, Bayer, and Grifols, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Hepatitis B Immunoglobulin(HBIG) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100IU/Bottle Human Hepatitis B Immunoglobulin
200IU/Bottle Human Hepatitis B Immunoglobulin
400IU/Bottle Human Hepatitis B Immunoglobulin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Hepatitis B Immunoglobulin(HBIG) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Hepatitis B Immunoglobulin(HBIG) by Country/Region, 2017, 2022 & 2028
2.2 Human Hepatitis B Immunoglobulin(HBIG) Segment by Type
2.2.1 100IU/Bottle Human Hepatitis B Immunoglobulin
2.2.2 200IU/Bottle Human Hepatitis B Immunoglobulin
2.2.3 400IU/Bottle Human Hepatitis B Immunoglobulin
2.3 Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
2.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
2.3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Type (2017-2022)
2.4 Human Hepatitis B Immunoglobulin(HBIG) Segment by Application
2.4.1 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
2.4.2 Unexpected Crowd of Hepatitis B Infection
2.4.3 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
2.5 Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
2.5.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sale Market Share by Application (2017-2022)
2.5.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Application (2017-2022)
3 Global Human Hepatitis B Immunoglobulin(HBIG) by Company
3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Breakdown Data by Company
3.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Sales by Company (2020-2022)
3.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Company (2020-2022)
3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Revenue by Company (2020-2022)
3.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Company (2020-2022)
3.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Company (2020-2022)
3.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Company
3.4 Key Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Product Location Distribution
3.4.2 Players Human Hepatitis B Immunoglobulin(HBIG) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Hepatitis B Immunoglobulin(HBIG) by Geographic Region
4.1 World Historic Human Hepatitis B Immunoglobulin(HBIG) Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Revenue by Geographic Region
4.2 World Historic Human Hepatitis B Immunoglobulin(HBIG) Market Size by Country/Region (2017-2022)
4.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Revenue by Country/Region
4.3 Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Growth
4.4 APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Growth
4.5 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Growth
4.6 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Growth
5 Americas
5.1 Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Country
5.1.1 Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022)
5.1.2 Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022)
5.2 Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
5.3 Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Region
6.1.1 APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2022)
6.1.2 APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2022)
6.2 APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
6.3 APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Hepatitis B Immunoglobulin(HBIG) by Country
7.1.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022)
7.1.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022)
7.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
7.3 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) by Country
8.1.1 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
8.3 Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin(HBIG)
10.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin(HBIG)
10.4 Industry Chain Structure of Human Hepatitis B Immunoglobulin(HBIG)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Hepatitis B Immunoglobulin(HBIG) Distributors
11.3 Human Hepatitis B Immunoglobulin(HBIG) Customer
12 World Forecast Review for Human Hepatitis B Immunoglobulin(HBIG) by Geographic Region
12.1 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size Forecast by Region
12.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Forecast by Region (2023-2028)
12.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Hepatitis B Immunoglobulin(HBIG) Forecast by Type
12.7 Global Human Hepatitis B Immunoglobulin(HBIG) Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.1.3 Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.2.3 CSL Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.3.3 Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.4.3 Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Octapharma
13.5.1 Octapharma Company Information
13.5.2 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.5.3 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Octapharma Main Business Overview
13.5.5 Octapharma Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Hualan Biological
13.7.1 Hualan Biological Company Information
13.7.2 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.7.3 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Biological Main Business Overview
13.7.5 Hualan Biological Latest Developments
13.8 China Biologic
13.8.1 China Biologic Company Information
13.8.2 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.8.3 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 China Biologic Main Business Overview
13.8.5 China Biologic Latest Developments
13.9 Tiantan Biologic
13.9.1 Tiantan Biologic Company Information
13.9.2 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Tiantan Biologic Main Business Overview
13.9.5 Tiantan Biologic Latest Developments
13.10 Shuanglin Bio-pharmacy
13.10.1 Shuanglin Bio-pharmacy Company Information
13.10.2 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shuanglin Bio-pharmacy Main Business Overview
13.10.5 Shuanglin Bio-pharmacy Latest Developments
13.11 Sichuan Yuanda Shuyang
13.11.1 Sichuan Yuanda Shuyang Company Information
13.11.2 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sichuan Yuanda Shuyang Main Business Overview
13.11.5 Sichuan Yuanda Shuyang Latest Developments
13.12 Boya Bio-pharmaceutical
13.12.1 Boya Bio-pharmaceutical Company Information
13.12.2 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Boya Bio-pharmaceutical Main Business Overview
13.12.5 Boya Bio-pharmaceutical Latest Developments
13.13 Shanghai Institute of Biological
13.13.1 Shanghai Institute of Biological Company Information
13.13.2 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Product Offered
13.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Institute of Biological Main Business Overview
13.13.5 Shanghai Institute of Biological Latest Developments
14 Research Findings and Conclusion
Table 1. Human Hepatitis B Immunoglobulin(HBIG) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Hepatitis B Immunoglobulin(HBIG) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100IU/Bottle Human Hepatitis B Immunoglobulin
Table 4. Major Players of 200IU/Bottle Human Hepatitis B Immunoglobulin
Table 5. Major Players of 400IU/Bottle Human Hepatitis B Immunoglobulin
Table 6. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 7. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
Table 8. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2022)
Table 10. Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Type (2017-2022) & (USD/Pcs)
Table 11. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 12. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Table 13. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022)
Table 14. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2022)
Table 15. Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Application (2017-2022) & (USD/Pcs)
Table 16. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Company (2020-2022) & (K Pcs)
Table 17. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Company (2020-2022)
Table 18. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Company (2020-2022)
Table 20. Global Human Hepatitis B Immunoglobulin(HBIG) Sale Price by Company (2020-2022) & (USD/Pcs)
Table 21. Key Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Producing Area Distribution and Sales Area
Table 22. Players Human Hepatitis B Immunoglobulin(HBIG) Products Offered
Table 23. Human Hepatitis B Immunoglobulin(HBIG) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Geographic Region (2017-2022) & (K Pcs)
Table 27. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Country/Region (2017-2022) & (K Pcs)
Table 31. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 35. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country (2017-2022)
Table 36. Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country (2017-2022)
Table 38. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 39. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
Table 40. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 41. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Table 42. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2022) & (K Pcs)
Table 43. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2017-2022)
Table 44. APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Region (2017-2022)
Table 46. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 47. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
Table 48. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 49. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Table 50. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 51. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country (2017-2022)
Table 52. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country (2017-2022)
Table 54. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 55. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
Table 56. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 57. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 59. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Human Hepatitis B Immunoglobulin(HBIG)
Table 67. Key Market Challenges & Risks of Human Hepatitis B Immunoglobulin(HBIG)
Table 68. Key Industry Trends of Human Hepatitis B Immunoglobulin(HBIG)
Table 69. Human Hepatitis B Immunoglobulin(HBIG) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Human Hepatitis B Immunoglobulin(HBIG) Distributors List
Table 72. Human Hepatitis B Immunoglobulin(HBIG) Customer List
Table 73. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 74. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Forecast by Region
Table 75. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 78. Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 80. APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Type (2023-2028) & (K Pcs)
Table 86. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Forecast by Application (2023-2028) & (K Pcs)
Table 90. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Baxter Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 95. Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 96. Baxter Main Business
Table 97. Baxter Latest Developments
Table 98. CSL Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 100. CSL Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. CSL Main Business
Table 102. CSL Latest Developments
Table 103. Bayer Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 105. Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Grifols Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 109. Grifols Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 110. Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Grifols Main Business
Table 112. Grifols Latest Developments
Table 113. Octapharma Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 114. Octapharma Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 115. Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. Octapharma Main Business
Table 117. Octapharma Latest Developments
Table 118. Shanghai RAAS Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 120. Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. Hualan Biological Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 124. Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 125. Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. Hualan Biological Main Business
Table 127. Hualan Biological Latest Developments
Table 128. China Biologic Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 129. China Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 130. China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. China Biologic Main Business
Table 132. China Biologic Latest Developments
Table 133. Tiantan Biologic Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 134. Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 135. Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 136. Tiantan Biologic Main Business
Table 137. Tiantan Biologic Latest Developments
Table 138. Shuanglin Bio-pharmacy Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 139. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 140. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 141. Shuanglin Bio-pharmacy Main Business
Table 142. Shuanglin Bio-pharmacy Latest Developments
Table 143. Sichuan Yuanda Shuyang Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 144. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 145. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 146. Sichuan Yuanda Shuyang Main Business
Table 147. Sichuan Yuanda Shuyang Latest Developments
Table 148. Boya Bio-pharmaceutical Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 149. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 150. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 151. Boya Bio-pharmaceutical Main Business
Table 152. Boya Bio-pharmaceutical Latest Developments
Table 153. Shanghai Institute of Biological Basic Information, Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base, Sales Area and Its Competitors
Table 154. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 155. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 156. Shanghai Institute of Biological Main Business
Table 157. Shanghai Institute of Biological Latest Developments
List of Figures
Figure 1. Picture of Human Hepatitis B Immunoglobulin(HBIG)
Figure 2. Human Hepatitis B Immunoglobulin(HBIG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100IU/Bottle Human Hepatitis B Immunoglobulin
Figure 10. Product Picture of 200IU/Bottle Human Hepatitis B Immunoglobulin
Figure 11. Product Picture of 400IU/Bottle Human Hepatitis B Immunoglobulin
Figure 12. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type in 2021
Figure 13. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2022)
Figure 14. Human Hepatitis B Immunoglobulin(HBIG) Consumed in Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Figure 15. Global Human Hepatitis B Immunoglobulin(HBIG) Market: Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg) (2017-2022) & (K Pcs)
Figure 16. Human Hepatitis B Immunoglobulin(HBIG) Consumed in Unexpected Crowd of Hepatitis B Infection
Figure 17. Global Human Hepatitis B Immunoglobulin(HBIG) Market: Unexpected Crowd of Hepatitis B Infection (2017-2022) & (K Pcs)
Figure 18. Human Hepatitis B Immunoglobulin(HBIG) Consumed in Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 19. Global Human Hepatitis B Immunoglobulin(HBIG) Market: Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers (2017-2022) & (K Pcs)
Figure 20. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2022)
Figure 21. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application in 2021
Figure 22. Human Hepatitis B Immunoglobulin(HBIG) Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Company in 2021
Figure 24. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Geographic Region in 2021
Figure 26. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2017-2022)
Figure 27. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country/Region in 2021
Figure 28. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2022 (K Pcs)
Figure 29. Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue 2017-2022 ($ Millions)
Figure 30. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2022 (K Pcs)
Figure 31. APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue 2017-2022 ($ Millions)
Figure 32. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2022 (K Pcs)
Figure 33. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2022 (K Pcs)
Figure 35. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue 2017-2022 ($ Millions)
Figure 36. Americas Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country in 2021
Figure 37. Americas Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country in 2021
Figure 38. United States Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region in 2021
Figure 43. APAC Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Regions in 2021
Figure 44. China Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country in 2021
Figure 51. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country in 2021
Figure 52. Germany Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Country in 2021
Figure 59. Egypt Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Human Hepatitis B Immunoglobulin(HBIG) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Human Hepatitis B Immunoglobulin(HBIG) in 2021
Figure 65. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin(HBIG)
Figure 66. Industry Chain Structure of Human Hepatitis B Immunoglobulin(HBIG)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...